DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,489,841 | -19.9% | 6,005 | -22.5% | 0.14% | -1.4% |
| Q2 2023 | $1,859,760 | -4.2% | 7,749 | +0.6% | 0.14% | -12.7% |
| Q1 2023 | $1,940,708 | +89540.1% | 7,700 | -5.6% | 0.16% | -15.4% |
| Q4 2022 | $2,165 | -99.9% | 8,157 | -1.9% | 0.20% | -9.3% |
| Q3 2022 | $2,149,000 | +7.3% | 8,319 | +5.3% | 0.22% | +7.5% |
| Q2 2022 | $2,002,000 | -17.5% | 7,897 | +7.0% | 0.20% | +4.2% |
| Q1 2022 | $2,427,000 | 0.0% | 7,378 | 0.0% | 0.19% | 0.0% |
| Q4 2021 | $2,427,000 | +10.2% | 7,378 | +2.0% | 0.19% | -2.5% |
| Q3 2021 | $2,202,000 | +15.5% | 7,234 | +1.8% | 0.20% | +15.2% |
| Q2 2021 | $1,907,000 | +20.6% | 7,107 | +1.2% | 0.17% | +10.3% |
| Q1 2021 | $1,581,000 | +4.4% | 7,024 | +3.0% | 0.16% | -4.9% |
| Q4 2020 | $1,515,000 | +9.2% | 6,820 | +5.9% | 0.16% | -8.4% |
| Q3 2020 | $1,387,000 | +21.9% | 6,440 | +0.0% | 0.18% | +11.9% |
| Q2 2020 | $1,138,000 | +36.6% | 6,437 | +7.0% | 0.16% | +1.3% |
| Q1 2020 | $833,000 | -0.1% | 6,017 | +16.0% | 0.16% | +18.9% |
| Q4 2019 | $834,000 | +1.2% | 5,188 | -9.0% | 0.13% | -12.6% |
| Q3 2019 | $824,000 | +20.1% | 5,702 | +18.8% | 0.15% | +9.4% |
| Q2 2019 | $686,000 | +14.9% | 4,799 | +6.1% | 0.14% | -4.8% |
| Q1 2019 | $597,000 | +189.8% | 4,523 | +126.6% | 0.14% | +93.3% |
| Q4 2018 | $206,000 | – | 1,996 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |